 
							all the business
domains in Alive
 
                                     
                                     
                                     
                                     
                                     
                                    
                
            
            About Project
                    
                    
            
		Willbe  is affiliated with all the business domains in Alive! Network which include media operation, brand development, e-commerce, wholesale and farm operation.		
	
		The Company will issue two separate tokens for use on the platform:
WillBeCoin – WBC 
WillBeToken – WBT 
		
	
		WillBe  users will be able to use their standard WBC tokens to pay for fees, for staking,for trading fee discounts, and for buying different features in the future when they are released.WBC will be the token distributed by the Company through the sales in the exchange or wallet .		
	
 
             
            
		Business Model & Supporters 		
	
Advertising revenue in the form of programmatic, direct display and pre-roll from endemic and national brands
            Licensing our brand IP (shows, logo, etc. ) to value adding networks and national brands
            Sponsorship revenue in the form of programmatic, direct display and pre-roll from endemic and national brands
            Direct to consumer events driving ticketing, merch and sponsorship revenue
            A hemp e-commerce store for Alive! and curated strategic partner products.
→ First original brand name “Willbe” with Vape and Gumi
→ Strategic partner product “Ignite”
https://ignite.co
https://www.instagram.com/danbilzerian
            → First original brand name “Willbe” with Vape and Gumi
→ Strategic partner product “Ignite”
https://ignite.co
https://www.instagram.com/danbilzerian
                
            
            Project Willbe
                    
                    
            
Marketplace
SupplyChain
Distribution
Cultivation
Franchise
		Far far away, behind the word mountains, far from the 
and Consonantia, there live the blinds  and Separated they live in Bookmarksgrove 
language ocean. A small river named Duden flows.		
	
Market
							The global cannabidiol (CBD) market has been estimated to reach USD 2,740 million in 2021 and is projected to grow at a CAGR of around 51% during the forecast period till 2030. The demand for CBD-based products is growing due to their healing properties for various health conditions and medical disorders. Heart diseases, cancer, anxiety, depression, pain relief, and inflammation are some health conditions that can be potentially treated using cannabidiol products. Cannabidiol (CBD) is one of the 113 cannabinoids identified in the cannabis plant. The CBD-based products include oil, dried cannabis, capsules, and liquid solution. The products can be consumed in multiple ways like inhaling smoke or vapor and eating.
						
				
							Government regulations also support CBD market growth. For instance, the U.S. Food and Drug Administration (FDA) has approved some of the purified forms of CBD products and concluded the benefits of CBD drug to be safe and effective. The growing clinical trials, research & development investments, and legalization of CBD in other parts of the globe can open new opportunities and further assist the cannabidiol (CBD) market growth.
						
				 
															 
															
                
            
            Significant Market Developments Considered in the Report:
                    
                    
            
In March 2021, Greenheart CBD, an Irish company has become the first CBD company to offer decentralized finance token. The token will help the company to expand and offer cost-effective products to its token holders.
    In November 2020, the Court of Justice of the European Union (CJEU) ruled that CBD is not narcotic and does not have any psychotropic effects on human health.
    In October 2020, the Dental College of Georgia and Medical College of Georgia demonstrated the ability of CBD to reduce inflammation and physical lung damage and improve oxygen levels related to adult respiratory distress syndrome.
    In June 2020, a biopharmaceutical company, Greater Cannabis Company Inc. announced the completion of the development, manufacturing, and shipment of 125,000 units of first order of oral CBD patch.
    